SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-134254
Filing Date
2021-04-27
Accepted
2021-04-27 16:16:27
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d147129ddefa14a.htm DEFA14A 15688
2 GRAPHIC g14712911_page1.jpg GRAPHIC 207315
3 GRAPHIC g14712922_page2.jpg GRAPHIC 120287
  Complete submission text file 0001193125-21-134254.txt   467902
Mailing Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703 (919) 237-5300
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36152 | Film No.: 21859121
SIC: 2836 Biological Products, (No Diagnostic Substances)